ARTICLE | Company News
Pinnacle Biologics, University of Chicago deal
July 4, 2011 7:00 AM UTC
Pinnacle's Pinnacle Oncology LLC subsidiary acquired worldwide rights to use the university's long site life cycle technology to develop amifostine as a genomic stabilizing agent. Pinnacle plans to us...